Press releases
EMA recommends temporary suspension of EQL Pharma drug, with reduced earnings for 2017 as a result
2017-04-03 The European Medicines Agency recommends a temporary withdrawal of a number of drugs for which bioequivalence studies has been conducted at Micro Therapeutic Research Labs, India.
Press Release 2017-04-03
-
2018-08-24Anders Månsson appointed new member of the Board of EQL Pharma AB
Anders Månsson has extensive experience from the pharmaceutical industry and has worked…
-
2018-08-22Report from the Annual General Meeting of EQL Pharma AB (publ) on August 22nd, 2018
Adoption of the balance sheet and income statement, disposition regarding the Company’s…
-
2018-06-26Acetazolamide EQL Pharma now approved for sale
Acetazolamide EQL Pharma is used as a short-term treatment for eye surgery…
-
2018-04-10Prednisolon EQL Pharma now approved for sale
Prednisolone EQL Pharma is used in the state where one needs to…
-
2018-02-27Paracetamol EQL Pharma approved
Paracetamol is a very common drug and sells in high volumes in…
-
2018-02-20Launch of Potassium chloride determined
Potassium chloride EQL Pharma is part of EQL Pharmas long-term commitment to…
-
2017-12-29EQL Pharma strengthens its organization with Axel Schörling, new Chief Operating Officer
He has a background as a management consultant at BearingPoint and most…
-
2017-11-24EQL Pharma signs agreement with leading generic company
EQL estimates that the profitability will be similar, whether EQL Pharma sells…
-
2017-07-05Positive news concerning the pharmaceutical product Eletriptan EQL Pharma
The pharmaceutical product Eletriptan EQL Pharma was approved Monday within the framework…
-
2017-07-03Zonisamid EQL Pharma launched in Denmark
Zonisamide EQL Pharma is an antiepileptic, used for the treatment of epilepsy.…
-
2017-05-17Report from the Annual General Meeting of EQL Pharma AB (publ) on May 15th, 2017
Adoption of the balance sheet and income statement, disposition regarding the Company’s…
-
2017-05-09Positive news concerning the pharmaceutical product Kaliumklorid EQL Pharma
The pharmaceutical product Kaliumklorid EQL Pharma (potassium chloride tablets) has today been…
-
2017-01-23The Nomination Committee for the Annual General Meeting in 2017
2017-01-23 In accordance with a resolution from the 2016 Annual General Meeting…
-
2016-11-16EQL Pharma strengthens its organization with Alexander Brising, New Business Development Director
EQL Pharma has recruited Alexander Brising as head of business development at…
-
2016-10-10Zonisamid EQL Pharma now approved in Denmark
The medical product Zonisamid EQL Pharma has now been approved for sale…
-
2016-01-21The Nomination Committee for the Annual General Meeting in 2016
In accordance with a resolution from the 2015 Annual General Meeting the…